FDA Forms Nanotechnology Task Force To Assess Technology

摘要

FDA's Nanotechnology Task Force will identify policy gaps related to the use of nanotechnology particles to evaluate possible adverse health effects from products that contain the materials,the agency said.Acting Commissioner Andrew von Eschenbach announced the formation of an internal FDA Nanotechnology Task Force Aug.9.The group is charged with developing regulatory approaches to encourage continued development of cosmetics,innovative drugs,devices and other products made with nanotechnology materials,FDA said.